证券代码：688234 证券简称：天岳先进 公告编号：2023-036 山东天岳先进科技股份有限公司 2023 年半年度募集资金存放与实际使用情况专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证监会《上市公司监管指引第 2 号——上市公司募集资金管理和使 用的监管要求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范 运作》和《上海证券交易所科创板股票上市规则》等相关规定，山东天岳先进科 技股份有限公司（以下简称"公司"）董事会编制了 2023 年半年度（以下简称"报 告期"、"本报告期"）募集资金存放与实际使用情况专项报告，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 根据中国证券监督管理委员会《关于同意山东天岳先进科技股份有限公司首 次公开发行股票注册的批复》（证监许可〔2021〕3935 号），公司首次公开发行人 民币普通股（A 股）42,971,105 股，全部为公开发行新股。每股面值人民币 1.00 元，每股发行价格为人民币 82.79 元，募集资金总 ...

山东天岳先进科技股份有限公司独立董事 关于第一届董事会第十九次会议相关议案的 独立意见 一、《关于公司 2023 年半年度募集资金存放与实际使用情况专项报告的议 案》 发表如下独立意见: 一、《关于公司 2023 年半年度募集资金存放与实际使用情况专项报告的议案》 公司编制的《2023 年半年度募集资金存放与实际使用情况专项报告》真实、 准确、完整地反映了公司 2023 年半年度的募集资金存放、使用和管理情况，符 合《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》等 相关法律法规和规范性文件的要求,公司对募集资金的管理和使用合法合规,不 存在变相改变募集资金用途、违规使用募集资金等情形,不存在应披露未披露的 情况，不存在损害公司和股东特别是中小股东利益的情形，不存在虚假记载、误 导性陈述或重大遗漏。 综上,我们同意公司 2023 年半年度募集资金存放与实际使用情况专项报告 的议案。 (以下无正文) （本页无正文，为《山东天岳先进科技股份有限公司独立董事关于第一届董事 会第十九次会议相关议案的独立意见》之签字页） 作为山东天岳先进科技股份有限公司(以下简称"公司")的独立董事,根据 《上市 ...

证券代码：688234 证券简称：天岳先进 公告编号：2023-035 山东天岳先进科技股份有限公司 第一届监事会第十七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 山东天岳先进科技股份有限公司（以下简称"公司"）第一届监事会第十七次 会议于 2023 年 8 月 28 日在公司会议室以现场结合通讯方式召开。会议由监事会 主席张红岩女士主持，应出席会议的监事 3 名，实际出席会议的监事 3 名。会议 参与表决人数及召集、召开程序符合《中华人民共和国公司法》和《公司章程》 的有关规定，所作决议合法有效。 二、监事会会议审议情况 本次监事会会议审议并通过了以下议案： 详见公司于同日在上海证券交易所网站披露的《2023 年半年度报告》。 表决结果：3 票同意，0 票反对，0 票弃权。 二、审议通过《关于公司 2023 年半年度募集资金存放与实际使用情况专项 报告的议案》 监事会认为：公司根据相关法律、法规、规范性文件以及公司《募集资金管 理办法》的规定，结合公司实际情况，编制了《山东天岳 ...

证券代码：688234 证券简称：天岳先进 公告编号：2023-034 山东天岳先进科技股份有限公司 关于签署框架采购协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1、合同类型：框架采购协议（以下简称"合同"、"本合同"、"本协议"） 2、合同金额：2024 年至 2026 年，公司向合同对方销售碳化硅产品，按照合 同《产品供货清单》，预计含税销售三年合计金额为人民币 80,480.00 万元。最终 以实际数量结算金额为准。 3、合同生效条件：经双方加盖公章或合同专用章且法定代表人或授权代表签 字之日起生效。 4、合同期限：有效期至 2026 年 12 月 31 日。 5、对上市公司当期业绩的影响：本次签署的合同总金额为预估金额，实际签 署订单将于合同有效期内分批执行。相关订单的履行预计将对公司的业绩产生积 极影响，公司将根据合同规定及收入确认原则在相应的会计期间确认收入。 6、特别风险提示： 6.1 本次签署的框架采购协议为合同双方基于合作意愿而达成的框架性协定， 预估含税总金额约为人民币 ...

证券代码：688234 证券简称：天岳先进 公告编号：2023-028 山东天岳先进科技股份有限公司 关于召开 2022 年度及 2023 年第一季度业绩暨 现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1、会议召开时间：2023 年 6 月 5 日（星期一）下午 16:00-17:00 2 、 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 3、会议召开方式：上证路演中心网络互动 4、会议问题征集：投资者可于 2023 年 5 月 29 日（星期一）至 6 月 2 日（星 期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司 邮箱 dmo@sicc.cc 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 山东天岳先进科技股份有限公司（以下简称"公司"）已于 2023 年 4 月 27 日 发布公司 2022 年年度报告及 2023 年第一季 ...

Financial Performance - The company's operating revenue for 2022 was approximately ¥417 million, a decrease of 15.56% compared to ¥494 million in 2021[18]. - The net profit attributable to shareholders for 2022 was approximately -¥175 million, representing a decline of 294.80% from a profit of ¥90 million in 2021[18]. - The net cash flow from operating activities for 2022 was -¥58.8 million, a decrease of 153.12% compared to ¥110.7 million in 2021[18]. - The total assets at the end of 2022 were approximately ¥5.87 billion, an increase of 124.02% from ¥2.62 billion at the end of 2021[18]. - The net assets attributable to shareholders at the end of 2022 were approximately ¥5.25 billion, an increase of 136.27% from ¥2.22 billion at the end of 2021[18]. - The revenue after deducting non-main business income for 2022 was approximately ¥417 million, down 15.22% from ¥492 million in 2021[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for 2022 was approximately -¥258 million, a decline of 2,087.09% from a profit of ¥13 million in 2021[18]. - The basic earnings per share decreased by 278.26% to -0.41 yuan per share[20]. - The weighted average return on equity decreased by 7.59 percentage points to -3.46%[20]. - The gross profit margin was negative due to product capacity adjustments, impacting overall profitability[70]. Research and Development - The company is focusing on the development of SiC and GaN semiconductor materials, which are critical for future technology advancements[12]. - The company aims to improve its product offerings through ongoing research and development initiatives in advanced semiconductor technologies[12]. - The company's R&D expenditure accounted for 30.59% of operating revenue, an increase of 15.66 percentage points from the previous year[20]. - R&D expenses for 2022 amounted to 127.56 million RMB, reflecting a commitment to advancing technology and innovation[31]. - The company achieved total R&D investment of ¥127,559,473.26 in the current year, representing a 72.99% increase compared to ¥73,736,131.22 in the previous year[54]. - The company applied for a total of 14 new patents during the reporting period, including 12 invention patents and 2 utility model patents[52]. - The company has developed high-purity silicon carbide powder with an active impurity concentration controlled below 0.05 ppm, ensuring high crystal purity and electrical performance[44]. - The company has made significant advancements in defect control technology during the silicon carbide single crystal growth process, addressing issues such as micropipes and polytype inclusions[46]. - The company has established a comprehensive talent training system, focusing on employee development and satisfaction[151]. Market Position and Strategy - The company maintained a market share in the semi-insulating silicon carbide substrate sector, ranking among the top three globally for four consecutive years[30]. - The company is actively exploring overseas markets by establishing a research and sales center in Japan[35]. - The company plans to expand its market presence and explore potential mergers and acquisitions to enhance growth opportunities[12]. - The company is committed to building a strong talent pool to support its R&D and production needs, implementing professional training programs and talent retention strategies[100]. - The company aims to enhance its production capacity and market share to narrow the gap with leading international firms, leveraging over a decade of R&D investment and technological innovation[99]. Governance and Compliance - The board of directors and supervisory board members have all attended the board meeting, ensuring governance compliance[5]. - The company has received a standard unqualified audit report from Lixin Certified Public Accountants[5]. - The company has confirmed that there are no violations of decision-making procedures for external guarantees[5]. - The company has maintained a high level of corporate governance, holding six board meetings and three shareholder meetings during the reporting period, with all resolutions passed[102]. - The company has established a comprehensive internal control system for its subsidiaries, enhancing management and operational efficiency[136]. Risks and Challenges - The company has outlined various operational risks and corresponding mitigation measures in the report[3]. - The company faces risks related to potential declines in performance due to macroeconomic factors affecting new capacity progress and increased salary expenses from hiring for new production lines[66]. - The company is at risk of knowledge leakage and talent loss, which could negatively impact its core competitiveness if internal controls are not effectively executed[67]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[5]. Sustainability and Social Responsibility - The company is committed to sustainability initiatives, aiming to reduce carbon emissions by 20% over the next three years[109]. - The company actively participates in social responsibility initiatives, including a donation of 30,000 RMB for environmental projects[138]. - The company has established a complete pollution treatment system, ensuring all pollutant emissions meet the required standards[143]. - The company has implemented energy consumption management measures, optimizing production processes to reduce overall energy consumption[141]. Shareholder and Financial Management - The company did not distribute cash dividends or bonus shares for the 2022 profit distribution plan, focusing on sustainable development and capital needs[4]. - The company has not proposed any capital reserve conversion into share capital for the 2022 fiscal year[4]. - The cumulative undistributed profits as of December 31, 2022, were -251.20 million RMB, indicating accumulated losses[70]. - The company has not proposed any cash profit distribution plans despite having positive distributable profits, indicating a focus on reinvestment[132]. - The company has committed to compensating investors for losses incurred due to unfulfilled commitments, with specific measures outlined for accountability[178].

Financial Performance - The company's operating revenue for Q1 2023 was ¥193,084,860.79, representing an increase of 185.44% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥28,156,102.73, with a decrease in losses attributed to increased operating revenue and improved gross margin[8]. - The company reported a net loss of CNY 279.36 million for the first quarter of 2023, compared to a net loss of CNY 251.20 million in the same period of the previous year[16]. - Net profit for Q1 2023 was a loss of ¥28,156,102.73, compared to a loss of ¥43,765,110.60 in Q1 2022, showing an improvement of approximately 35.8%[19]. - The company reported a total comprehensive loss of ¥29,186,567.45 for Q1 2023, compared to a loss of ¥44,030,312.98 in Q1 2022, indicating an improvement of approximately 33.6%[20]. - The total comprehensive income for Q1 2023 was -14,143,336.38 RMB, an improvement from -43,053,373.54 RMB in Q1 2022[30]. Cash Flow - The net cash flow from operating activities was -¥58,287,032.14, indicating ongoing cash flow challenges[4]. - Cash inflow from operating activities in Q1 2023 totaled ¥274,471,887.97, compared to ¥120,367,236.33 in Q1 2022, marking an increase of about 128.5%[21]. - Cash outflow from operating activities for Q1 2023 was ¥332,758,920.11, compared to ¥189,867,818.60 in Q1 2022, resulting in a net cash outflow of ¥58,287,032.14[22]. - In Q1 2023, the company reported a net cash flow from operating activities of -36,324,966.05 RMB, an improvement from -81,714,834.55 RMB in Q1 2022, indicating a 55.5% reduction in losses[31]. - The company recorded a net cash inflow from investment activities of 402,894,915.92 RMB in Q1 2023, contrasting with a net outflow of -194,942,857.63 RMB in Q1 2022[32]. - The company experienced a net increase in cash and cash equivalents of 366,569,949.87 RMB in Q1 2023, compared to a significant increase of 2,926,778,796.75 RMB in Q1 2022[32]. Research and Development - R&D investment totaled ¥38,783,368.56, marking a 101.11% increase, driven by enhanced focus on product innovation and technology investment[8]. - The proportion of R&D investment to operating revenue was 20.09%, a decrease of 8.42 percentage points year-on-year[4]. - Research and development expenses for Q1 2023 amounted to ¥38,783,368.56, up from ¥19,284,785.50 in Q1 2022, indicating an increase of approximately 100.0%[18]. - The company's R&D expenses for Q1 2023 were ¥38,783,368.56, up from ¥19,284,785.50 in Q1 2022, reflecting an increase of about 100.3%[27]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,767,413,926.82, a decrease of 1.68% from the end of the previous year[5]. - The company's total assets amounted to approximately CNY 5.77 billion, a decrease from CNY 5.87 billion as of December 31, 2022, representing a decline of about 1.2%[16]. - The company's total non-current assets rose to CNY 2.82 billion from CNY 2.55 billion, indicating an increase of approximately 10.6%[15]. - The company's total liabilities decreased to CNY 545.48 million from CNY 614.61 million, a reduction of about 11.3%[16]. - The total current liabilities decreased to CNY 233.33 million from CNY 312.96 million, reflecting a reduction of about 25.4%[16]. - The total liabilities as of March 31, 2023, were ¥359,602,916.10, down from ¥388,508,447.91 at the end of 2022, indicating a reduction of approximately 7.4%[26]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,040, with the largest shareholder holding 30.09% of the shares[9]. - The company's total equity attributable to shareholders decreased to CNY 5.22 billion from CNY 5.25 billion, a decline of about 0.6%[16]. - The company's total equity as of March 31, 2023, was ¥5,277,118,875.53, down from ¥5,293,756,856.10 at the end of 2022, reflecting a decrease of approximately 0.3%[26]. Inventory and Receivables - The company's inventory as of March 31, 2023, was CNY 513.78 million, slightly down from CNY 533.28 million, a decrease of about 3.7%[14]. - The company's accounts receivable increased to CNY 161.66 million from CNY 138.00 million, representing an increase of approximately 17.2%[14]. - The company reported a decrease in accounts payable from ¥98,937,077.88 in 2022 to ¥66,759,570.85 in Q1 2023, indicating a reduction of about 32.5%[25]. Other Income - The company reported non-recurring gains of ¥17,409,834.26, primarily from government subsidies and other non-operating income[7]. - Other income for Q1 2023 was ¥7,942,569.64, compared to ¥5,513,458.00 in Q1 2022, representing an increase of about 43.9%[18].

Financial Performance - The company's operating revenue for Q3 2022 was ¥108,674,842.39, a decrease of 11.57% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2022 was -¥44,488,106.80, representing a decline of 890.71% year-over-year[4]. - Total operating revenue for the first three quarters of 2022 was CNY 269,484,703.56, a decrease of 27.2% compared to CNY 370,103,451.60 in the same period of 2021[17]. - Net profit for the third quarter was a loss of CNY 117,330,968.60, compared to a profit of CNY 53,534,321.78 in the previous year[19]. - The total comprehensive income attributable to the parent company for Q3 2022 was -117,739,577.42 RMB, a decline from 53,190,863.81 RMB in Q3 2021[20]. - The net profit for Q3 2022 was a loss of CNY 110,626,304.42, compared to a profit of CNY 62,457,405.55 in Q3 2021, indicating a significant decline in profitability[30]. Research and Development - The total R&D investment in Q3 2022 was ¥34,161,697.39, an increase of 16.22% compared to the same period last year[4]. - R&D expenses accounted for 31.43% of operating revenue in Q3 2022, an increase of 7.51 percentage points year-over-year[5]. - Research and development expenses for the first three quarters reached CNY 87,296,725.34, an increase of 22.8% from CNY 71,067,011.22 in the same period of 2021[17]. - Research and development expenses for the first three quarters of 2022 totaled CNY 63,278,602.77, down from CNY 71,067,011.22 in the same period of 2021, reflecting a decrease of approximately 10.5%[28]. Assets and Liabilities - Total assets at the end of Q3 2022 reached ¥5,865,688,050.58, reflecting a growth of 124.01% compared to the end of the previous year[5]. - Total liabilities increased to CNY 557,289,353.43, compared to CNY 395,971,914.98 in the previous year, reflecting a growth of 40.6%[15]. - The company's total assets increased to CNY 5,675,165,206.56, up from CNY 2,530,017,761.58, representing a growth of approximately 124.7% year-over-year[27]. - The total liabilities increased to CNY 356,630,153.82, up from CNY 304,530,442.29, marking an increase of approximately 17.1% year-over-year[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,489, with no preferred shareholders having restored voting rights[9]. - The largest shareholder, Zong Yanmin, holds 30.09% of the shares, amounting to 129,302,726 shares[9]. - The total number of shares held by the top ten shareholders accounted for 63.91% of the total shares[9]. - The company has no significant changes in the status of pledged, marked, or frozen shares among the top shareholders[9]. - There were no financing or margin trading activities reported among the top ten shareholders[11]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥31,630,750.95, a decline of 156.34% year-over-year[4]. - The cash flow from operating activities in Q3 2022 was 488,292,977.63 RMB, down from 549,272,994.64 RMB in Q3 2021[23]. - The company's cash flow from operating activities showed a net outflow of CNY 33,924,584.52 in the first three quarters of 2022, compared to a net inflow of CNY 47,010,554.94 in the same period of 2021[31]. - Cash inflow from financing activities amounted to approximately 3.24 billion, with no prior period data available[32]. - The company's cash flow from financing activities netted 3,200,311,653.18 RMB in Q3 2022, indicating a strong capital influx compared to the previous year[24]. Inventory and Receivables - Inventory increased to ¥487,383,373.00 from ¥385,573,601.60, reflecting a rise of 26.39%[13]. - The company reported accounts receivable of ¥108,272,580.06, up from ¥57,787,546.59, marking an increase of 87.06%[13]. - The company reported a significant increase in accounts payable, which rose to CNY 110,839,028.04 from CNY 75,069,878.23, an increase of approximately 47.6%[27]. Other Information - The company faced challenges in production capacity and sales due to the pandemic and international situation, impacting revenue and profit margins[8]. - The company did not provide any significant updates on new product development or market expansion strategies during the reporting period[12]. - The company has not adopted new accounting standards or interpretations that would affect the financial statements for the current year[33].